AT350183B - Verfahren zur herstellung eines cephalosporin- derivates, dessen monohydrates, sowie dessen salzen - Google Patents

Verfahren zur herstellung eines cephalosporin- derivates, dessen monohydrates, sowie dessen salzen

Info

Publication number
AT350183B
AT350183B AT296277A AT296277A AT350183B AT 350183 B AT350183 B AT 350183B AT 296277 A AT296277 A AT 296277A AT 296277 A AT296277 A AT 296277A AT 350183 B AT350183 B AT 350183B
Authority
AT
Austria
Prior art keywords
monohydrates
salts
producing
cephalosporine derivative
cephalosporine
Prior art date
Application number
AT296277A
Other languages
English (en)
Other versions
ATA296277A (de
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10087928&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT350183(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ATA296277A publication Critical patent/ATA296277A/de
Application granted granted Critical
Publication of AT350183B publication Critical patent/AT350183B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT296277A 1976-04-27 1977-04-27 Verfahren zur herstellung eines cephalosporin- derivates, dessen monohydrates, sowie dessen salzen AT350183B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB17028/76A GB1532682A (en) 1976-04-27 1976-04-27 Process for the preparation of cephadroxil

Publications (2)

Publication Number Publication Date
ATA296277A ATA296277A (de) 1978-10-15
AT350183B true AT350183B (de) 1979-05-10

Family

ID=10087928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT296277A AT350183B (de) 1976-04-27 1977-04-27 Verfahren zur herstellung eines cephalosporin- derivates, dessen monohydrates, sowie dessen salzen

Country Status (26)

Country Link
US (3) US4234721A (de)
JP (2) JPS6022717B2 (de)
AT (1) AT350183B (de)
AU (1) AU510338B2 (de)
BE (1) BE853974A (de)
CA (1) CA1115268A (de)
CH (1) CH632270A5 (de)
CY (1) CY1066A (de)
DE (1) DE2718741C2 (de)
DK (1) DK157026C (de)
ES (1) ES458241A1 (de)
FI (1) FI67704C (de)
FR (2) FR2349589A1 (de)
GB (1) GB1532682A (de)
GR (1) GR72788B (de)
HK (1) HK39780A (de)
IE (1) IE44872B1 (de)
IT (1) IT8049917A0 (de)
KE (1) KE3064A (de)
LU (1) LU77202A1 (de)
MY (1) MY8100135A (de)
NL (1) NL7704618A (de)
PH (2) PH16581A (de)
SE (1) SE437521B (de)
YU (2) YU39801B (de)
ZA (1) ZA772485B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT386411B (de) * 1983-12-06 1988-08-25 Bristol Myers Co Verfahren zur herstellung von neuem kristallinem 7-d-alpha-amino-alpha-(3-chlor-4-hydroxyphenyl) acetamido)-3-methyl-3-cephem-4-carbonsaeuremonohydrat

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR820001564B1 (ko) * 1981-05-09 1982-09-02 동신제약 주식회사 새로운 실릴화제를 이용한 세팔로스포린 유도체의 제조방법
JPS60169486A (ja) * 1984-02-10 1985-09-02 Yamanouchi Pharmaceut Co Ltd ７−アミノ−３−置換メチル−３−セフエム−４−カルボン酸およびその低級アルキルシリル誘導体の製造法
GB8714180D0 (en) * 1987-06-17 1987-07-22 Rifar Srl Anhydrous crystalline cefadroxil
US5023331A (en) * 1987-04-24 1991-06-11 Rifar S.R.L. Cefadroxil solvates
US4904776A (en) * 1987-04-24 1990-02-27 Rifar S.R.L. Method for producing crystalline cefadroxil hemihydrate
US4962195A (en) * 1987-04-24 1990-10-09 Rifar S.R.L. Solvate of cefadroxyl
US4898938A (en) * 1987-08-03 1990-02-06 Rifar S.R.L. Method for preparing crystalline cefadroxil monohydrate
IT1233863B (it) * 1988-02-24 1992-04-21 Opos Biochimica Srl Procedimento per la preparazione dell'acido 7-(d(-)-alfa-amino-alfa- (p-idrossifenil)acetamido)-3-metil-3-cefem-4-carbossilico monoidrato
US5034522A (en) * 1988-08-02 1991-07-23 Biocraft Laboratories, Inc. Method for the production of 3-methyl cephem derivatives
EP0433428B1 (de) * 1989-07-10 1994-10-12 Chemferm V.O.F. Stabile form von cephradin, verfahren zu dessen herstellung und darin verwendete zwischenprodukte
US5142043A (en) * 1990-05-10 1992-08-25 Biocraft Laboratories, Inc. Process for preparing cephalexin monohydrate
US6248881B1 (en) 1991-03-08 2001-06-19 Biochemie Gmbh Intermediates and process for the production of 3-vinyl cephalosporins
ATE201025T1 (de) 1991-03-08 2001-05-15 Biochemie Gmbh Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren
AT396106B (de) * 1991-03-08 1993-06-25 Biochemie Gmbh Neues verfahren zur herstellung von 3-vinylcephalosporinverbindungen
CA2155322C (en) * 1993-03-12 2000-02-29 Michael J. Dunn Crystalline ceftiofur free acid
US5604222A (en) * 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
MX9604831A (es) 1994-04-15 1998-05-31 Upjohn Co Formas nuevas de cristal de 1-[5-metanosulfonamidoindolil-2-carbonil]-4-[3-(1-metiletila mino)-2-piridinil]-piperazina.
US5578721A (en) * 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
IT1289955B1 (it) * 1997-02-21 1998-10-19 Solchem Italiana Spa Acyclovir sale sodico biidrato e sua preparazione
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
IN190389B (de) 1999-07-14 2003-07-26 Ranbaxy Lab Ltd
AU5418300A (en) * 1999-07-14 2001-01-30 Ranbaxy Laboratories Limited Process for preparing crystalline cefadroxil hemihydrate from cefadroxil dimethylformamide solvate
US20060173064A1 (en) * 2001-08-24 2006-08-03 Lippa Arnold S (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
US20080081834A1 (en) 2002-07-31 2008-04-03 Lippa Arnold S Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
US20040077849A1 (en) * 2002-10-16 2004-04-22 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefadroxil
EP1562900A4 (de) * 2002-11-08 2006-07-12 Dov Pharmaceutical Inc Polymorphe von bicifadinhydrochlorid
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US7230097B2 (en) 2003-03-10 2007-06-12 Lupin Ltd. Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
US20070072945A1 (en) * 2004-03-31 2007-03-29 Pohoreski Anton Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
CN104059013B8 (zh) 2005-07-27 2016-09-21 纽若范斯有限公司 1-芳基-3-氮杂二环[3.1.0]己烷：其制备方法和用于治疗神经精神障碍的用途
US20080045725A1 (en) * 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
BRPI0711924B1 (pt) * 2006-05-19 2023-11-28 Centrient Pharmaceuticals Netherlands B.V. Processo para a preparação de cefadroxil monoidratado em forma de cristal
US20080269348A1 (en) * 2006-11-07 2008-10-30 Phil Skolnick Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
US8138377B2 (en) * 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
DK2118074T3 (en) 2007-02-01 2014-03-10 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular diseases
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
WO2008153937A2 (en) * 2007-06-06 2008-12-18 Dov Pharmaceutical, Inc. Novel 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
NZ755378A (en) 2009-03-18 2022-07-29 Resverlogix Corp Novel quinazolinones and related compounds for use as anti-inflammatory agents
CN102408438B (zh) * 2010-09-26 2015-01-07 石药集团中奇制药技术（石家庄）有限公司 一种头孢丙烯一水合物的制备方法
CN102134250B (zh) * 2011-01-19 2013-03-13 天津大学 一种头孢羟氨苄单水合物的结晶方法及结晶

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29164A (en) * 1860-07-17 Improvement in fish-oils
US3489752A (en) * 1967-09-05 1970-01-13 Bristol Myers Co 7-amino-cephalosporanic and decephalosporanic acid derivatives
USRE29164E (en) 1967-09-05 1977-03-29 Bristol-Myers Company 7-Amino-cephalosporanic and decephalosporanic acid derivatives
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
US3694437A (en) * 1970-08-19 1972-09-26 Lilly Co Eli Process for preparing cephalosporin compounds
US3781282A (en) * 1971-01-20 1973-12-25 W Garbrecht Cephalosporin process and product
JPS5318515B2 (de) 1971-12-17 1978-06-15
DE2163514A1 (de) * 1971-12-21 1973-07-05 Toyama Chemical Co Ltd Verfahren zur herstellung von cephalosporinen
FR2166316A1 (en) * 1972-01-07 1973-08-17 Toyama Chemical Co Ltd 7-acylcephalosporins - prepd via a silylated inter
US3985741A (en) * 1972-09-15 1976-10-12 Bristol-Myers Company Production of p-hydroxycephalexin
BE806868A (fr) 1972-11-02 1974-02-15 Lorenzini Sas Inst Biochim Procede de preparation de l'acide 7-(d-alpha-aminophenylacetamido) -3-desacetoxycephalosporanique
GB1472746A (en) * 1973-07-05 1977-05-04 Glaxo Lab Ltd Cephalosporin compounds
GB1476981A (en) 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
US4091215A (en) * 1974-06-05 1978-05-23 Bristol-Myers Company 7-D-α-Amino-.alpha.-(p-acetoxyphenyl)acetamido-3-methyl-3-cephem-4-carboxylic acid
AU2550077A (en) * 1976-06-14 1978-11-30 Merck Patent Gmbh Penicillins and cephalosporins
US4160863A (en) * 1977-04-07 1979-07-10 Bristol-Myers Company Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid
NL162387C (nl) * 1977-09-06 1980-05-16 Gist Brocades Nv Werkwijze voor het bereiden van 6-(d-alpha-amino-p- -hydroxyfenylacetamido)penicillanzuur.
IT1126544B (it) * 1979-12-07 1986-05-21 Dobfar Spa Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT386411B (de) * 1983-12-06 1988-08-25 Bristol Myers Co Verfahren zur herstellung von neuem kristallinem 7-d-alpha-amino-alpha-(3-chlor-4-hydroxyphenyl) acetamido)-3-methyl-3-cephem-4-carbonsaeuremonohydrat

Also Published As

Publication number Publication date
SE7704739L (sv) 1977-12-01
AU510338B2 (en) 1980-06-19
NL7704618A (nl) 1977-10-31
YU39801B (en) 1985-04-30
DK157026C (da) 1990-04-02
FR2365570B1 (de) 1980-06-06
CA1115268A (en) 1981-12-29
YU43081B (en) 1989-02-28
SE437521B (sv) 1985-03-04
JPS52142091A (en) 1977-11-26
KE3064A (en) 1980-07-25
US4234721A (en) 1980-11-18
US4504657A (en) 1985-03-12
FR2365570A1 (fr) 1978-04-21
FR2349589B1 (de) 1981-11-20
GB1532682A (en) 1978-11-22
IE44872B1 (en) 1982-04-21
PH16581A (en) 1983-11-22
IE44872L (en) 1977-10-27
BE853974A (fr) 1977-10-26
JPS6022717B2 (ja) 1985-06-03
HK39780A (en) 1980-08-08
LU77202A1 (de) 1977-11-22
CH632270A5 (de) 1982-09-30
DE2718741A1 (de) 1977-11-17
USRE31730E (en) 1984-11-13
ZA772485B (en) 1978-03-29
JPS60185718A (ja) 1985-09-21
PH17254A (en) 1984-07-03
FI67704B (fi) 1985-01-31
MY8100135A (en) 1981-12-31
FI771339A (de) 1977-10-28
DE2718741C2 (de) 1985-03-21
ATA296277A (de) 1978-10-15
YU137982A (en) 1983-04-30
ES458241A1 (es) 1978-11-01
IT8049917A0 (it) 1980-10-16
DK183277A (da) 1977-10-28
AU2460777A (en) 1978-11-02
JPH0246009B2 (de) 1990-10-12
YU108677A (en) 1982-10-31
FR2349589A1 (fr) 1977-11-25
CY1066A (en) 1980-10-24
DK157026B (da) 1989-10-30
FI67704C (fi) 1985-05-10
GR72788B (de) 1983-12-05

Similar Documents

Publication Publication Date Title
AT350183B (de) Verfahren zur herstellung eines cephalosporin- derivates, dessen monohydrates, sowie dessen salzen
DD133519A5 (de) Verfahren zur herstellung eines stuetzverbands
AT355238B (de) Verfahren zur herstellung eines neuen hentriakontapeptids
ATA971776A (de) Verfahren zur herstellung eines stabilen antibiotischen praparates
ATA102477A (de) Verfahren zur herstellung eines retroreflektierenden bahnenmaterials
AT355523B (de) Verfahren zur herstellung eines gurtbandes
AT369988B (de) Verfahren zur herstellung eines coccidienbekaempfungsmittels
AT386744B (de) Verfahren zur herstellung eines wundheilmittels
AT361718B (de) Verfahren zur herstellung eines schichtkoerpers
ATA531277A (de) Verfahren zur herstellung eines stickstoff- haltigen polysaccharids
AT357407B (de) Verfahren zur herstellung eines speckaehnlichen produktes
AT388135B (de) Verfahren zur herstellung eines luftreifens
AT360512B (de) Verfahren zur herstellung eines d-enantiomeren indolderivats
DD132466A1 (de) Verfahren zur herstellung eines vitaminproduktes
AT356494B (de) Verfahren zur herstellung eines gewuerzaroma- extraktes
AT358792B (de) Verfahren zur herstellung eines doppelbodens
AT358723B (de) Verfahren zur herstellung eines lipasereichen enzympraeparates
AT362214B (de) Verfahren zur herstellung eines schichtstoffes
AT362055B (de) Verfahren zur herstellung eines stabilen baldrianextraktpraeparates
AT388134B (de) Verfahren zur herstellung eines luftreifens
AT357855B (de) Verfahren zur herstellung eines pektin- praeparates
AT356295B (de) Verfahren zur herstellung eines neuen morphanderivates
DD133672A5 (de) Verfahren zur herstellung eines saeureadditionssalzes
AT361527B (de) Verfahren zur herstellung eines verbundwerk- stoffes
AT364826B (de) Verfahren zur herstellung neuer morphinanderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELA Expired due to lapse of time